These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14980648)

  • 61. [Bisphosphonates inhibit matrix metalloproteinases--a new possible mechanism of action].
    Teronen O; Konttinen YT; Salo T; Lindqvist C; Heikkilä P; Laitinen M; Sorsa T
    Duodecim; 1999; 115(1):13-5. PubMed ID: 11830856
    [No Abstract]   [Full Text] [Related]  

  • 62. Characterisation of a novel matrix metalloproteinase inhibitor on pancreatic adenocarcinoma cells in vitro and in an orthotopic pancreatic cancer model in vivo.
    Kapischke M; Fischer T; Tiessen K; Tschesche H; Bruch HP; Kalthoff H; Kruse ML
    Int J Oncol; 2008 Jan; 32(1):273-82. PubMed ID: 18097568
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Targeting matrix metalloproteinases: design of a bifunctional inhibitor for presentation by tumour-associated galectins.
    Bartoloni M; Domínguez BE; Dragoni E; Richichi B; Fragai M; André S; Gabius HJ; Ardá A; Luchinat C; Jiménez-Barbero J; Nativi C
    Chemistry; 2013 Feb; 19(6):1896-902. PubMed ID: 23280962
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Sulphonamides: Deserving class as MMP inhibitors?
    Jain P; Saravanan C; Singh SK
    Eur J Med Chem; 2013 Feb; 60():89-100. PubMed ID: 23287054
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Selectivity, binding affinity, and ionization state of matrix metalloproteinase inhibitors.
    Zhong HA; Arbiser J; Bowen JP
    Curr Pharm Des; 2013; 19(26):4701-13. PubMed ID: 23260023
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Enzymatic activation of a matrix metalloproteinase inhibitor.
    Major Jourden JL; Cohen SM
    Chem Commun (Camb); 2010 Feb; 46(8):1241-3. PubMed ID: 20449263
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.
    Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2002 Oct; 12(19):2667-72. PubMed ID: 12217351
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The next generation of MMP inhibitors. Design and synthesis.
    De B; Natchus MG; Cheng M; Pikul S; Almstead NG; Taiwo YO; Snider CE; Chen L; Barnett B; Gu F; Dowty M
    Ann N Y Acad Sci; 1999 Jun; 878():40-60. PubMed ID: 10415719
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Investigation of self-immolative linkers in the design of hydrogen peroxide activated metalloprotein inhibitors.
    Jourden JL; Daniel KB; Cohen SM
    Chem Commun (Camb); 2011 Jul; 47(28):7968-70. PubMed ID: 21677985
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Role of matrix metalloproteinases in mesangial proliferative glomerulonephritis.
    Marti HP
    Kidney Blood Press Res; 2000; 23(3-5):199-201. PubMed ID: 11031721
    [No Abstract]   [Full Text] [Related]  

  • 71. Can exogenous protease inhibitors control dentin matrix degradation?
    Carrilho MR
    J Dent Res; 2012 Dec; 91(12):1099-102. PubMed ID: 23023764
    [No Abstract]   [Full Text] [Related]  

  • 72. Novel matrix metallo-proteinase (MMP-2) phosphonoboronate inhibitors.
    Pergament I; Reich R; Srebnik M
    Bioorg Med Chem Lett; 2002 Apr; 12(8):1215-8. PubMed ID: 11934591
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Matrix metalloproteinases and their native or pharmacologic inhibitors.
    Raza SL; Cornelius LA
    Adv Dermatol; 2000; 16():185-208; discussion 209. PubMed ID: 11094628
    [No Abstract]   [Full Text] [Related]  

  • 74. Matrix metalloproteinase inhibitors: specificity of binding and structure-activity relationships.
    Gupta SP
    Exp Suppl; 2012; 103():v-vi. PubMed ID: 22642187
    [No Abstract]   [Full Text] [Related]  

  • 75. Matrix metalloproteinases.
    Fridman R
    Biochim Biophys Acta; 2010 Jan; 1803(1):1-2. PubMed ID: 20159302
    [No Abstract]   [Full Text] [Related]  

  • 76. [Matrix metalloproteinases in periodontal disease].
    Grinin VM; Baiar U; Karaoglanova TB
    Stomatologiia (Mosk); 2011; 90(6):80-4. PubMed ID: 22448409
    [No Abstract]   [Full Text] [Related]  

  • 77. Inhibiting metalloproteinase inhibitors?
    Miller EB; Green L
    Isr Med Assoc J; 2000 Mar; 2(3):261. PubMed ID: 10774286
    [No Abstract]   [Full Text] [Related]  

  • 78. Preface - Matrix metalloproteinases.
    Fridman R
    Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1925-1926. PubMed ID: 28739264
    [No Abstract]   [Full Text] [Related]  

  • 79. Matrix metalloproteinases in thyroid cancer.
    Shi Y; Zou M
    Cancer Treat Res; 2004; 122():179-90. PubMed ID: 16209045
    [No Abstract]   [Full Text] [Related]  

  • 80. Proteolysis in the lung.
    Shapiro SD
    Eur Respir J Suppl; 2003 Sep; 44():30s-32s. PubMed ID: 14582898
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.